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E-mail address: yekeqiong@nibs.ac.cn (K. Ye).Mutator 2 (MU2) in Drosophila melanogaster has been proposed to be the ortholog of human MDC1,
a key mediator in DNA damage response. The forkhead-associated (FHA) domain of MDC1 is a dimer-
ization module regulated by trans binding to phosphothreonine 4 from another molecule. Here we
present the crystal structure of the MU2 FHA domain at 1.9 Å resolution, revealing its evolutionarily
conserved role in dimerization. As compared to the MDC1 FHA domain, the MU2 FHA domain
dimerizes using a different and more stable interface and contains a degenerate phosphothreo-
nine-binding pocket. Our results suggest that the MU2 dimerization is constitutive and lacks
phosphorylation-mediated regulation.
Structured summary of protein interactions:
MU2 and MU2 bind by cosedimentation in solution (View interaction)
MU2 and MU2 bind by X-ray crystallography (View interaction)
MU2 and MU2 bind by molecular sieving (View interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction the ubiquitin ligase RNF8 [11–13]. The SDT motif is constitutivelyDNA double-strand breaks (DSBs) produced by genotoxic agents
and in normal cellular processes are highly harmful to genome sta-
bility. Eukaryotes employ sophisticated DNA damage responses
(DDR) to detect DSBs, transduce their signal and repair them [1].
One of the earliest events upon induction of DSB is rapid phosphor-
ylation of Ser139 near the C-terminus of the histone variant H2AX
[2]. Phosphorylated H2AX (cH2AX) forms a platform on which a
host of checkpoint and repair proteins assemble into discrete nu-
clear foci. Mediator of DNA damage checkpoint protein 1 (MDC1,
also known as NFBD1) is a key mediator protein that organizes
and maintains DNA damage foci in mammalian DDR [3–17].
MDC1 mediates multiple phosphorylation-dependent protein–
protein interactions [18]. It is composed of an N-terminal forkhead-
associated (FHA) domain, a long linker region harboring repetitive
short SDT, TQXF and PST motifs, and a tandem BRCT domain at the
C-terminus. The tandem BRCT domain binds phospho-Ser139 of
cH2AX [7–9]. The TQXF motif is phosphorylated by ATM and bindschemical Societies. Published by E
of DNA damage checkpoint
age response; DSB, double-phosphorylated at its serine and threonine residues by casein kinase
2 and recruits the Mre11–Rad50–NBS1 (MRN) complex via its inter-
action with NBS1 [14–17]. FHA domains are phosphothreonine
(pThr) speciﬁc-binding domains that are widely present in DNA re-
pair and checkpoint proteins [19]. The FHAdomain ofMDC1has been
reported to interact with CHK2, ATM and Rad51 [6,9,10]; however,
the relevance of these interactions is unclear [18].
The MDC1 FHA domain was recently shown to form a dimer
through asymmetric face-to-face b-sheet contacts [20–22]. The di-
mer interface is marginally stable by itself, but can be greatly
strengthened by the intermolecular interaction of one FHA subunit
with the phosphorylated threonine 4 (pThr4) at the N-terminus of
the other FHA subunit in dimer [20,21]. The Thr4 residue is phos-
phorylated primarily by ATM in response to DNA damage, provid-
ing a mechanism that regulates MDC1 dimer formation and
function [20,21]. It was reported that MDC1 Thr98 is phosphory-
lated by ATM, inducing MDC1 self-association [23]. However, this
conclusion has been challenged since Thr98 is totally buried in
the FHA structure and inaccessible to phosphorylation [20,21].
The MDC1 interacting partners cH2AX and the MRN complex
are evolutionarily conserved from yeast to humans. However, no
homologs of MDC1 are apparent in lower eukaryotes. Drosophila
mutator 2 (MU2) has been proposed as the ortholog of MDC1 based
on the similarities in sequence and function [24]. First, they sharelsevier B.V. All rights reserved.
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a C-terminal tandem BRCT domain (Fig. 1A). Second, their tandem
BRCT domains all bind cH2AX (cH2Av in Drosophila). MU2 like-
wise forms DNA damage foci that co-localize with cH2Av foci.
Third, an N-terminal fragment of MU2 associates with the MRN
complex. Fourth, MU2 has been genetically linked to DSB repair;
a mutation in the mu2 gene led to defects in DSB repair and an in-
creased frequency of neotelomeres [24–27].
MU2 and MDC1 share only 10% sequence identity and 22% sim-
ilarity in the FHA domain. It is unknown whether the dimerization
function of the FHA domain is evolutionarily conserved in MU2. In
this study, we determined the crystal structure of the MU2 FHA do-
main, revealing also a dimer. This identiﬁes a new structural corre-
spondence between MU2 and MDC1 and suggests a conserved role
for FHA dimerization in MDC1/MU2 functions. However, the MU2
FHA dimer has a different dimer interface with higher intrinsic sta-
bility and a degenerate pThr-binding pocket as compared to the
MDC1 FHA domain.
2. Materials and methods
2.1. Gene cloning and protein puriﬁcation
The DNA sequence encoding residues 1–101 of MU2 (CG1960)
was PCR ampliﬁed from a Drosophila cDNA clone obtained fromN
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Fig. 1. Dimeric structure of the MU2 FHA domain. (A) Domain diagram of MU2 and MDC1
colored green and blue. Two orientations, which are viewed down and perpendicular to t
are labeled. (C) Structural superimposition of MU2 (green and blue) and MDC1 FHA dime
shown as tubes, interacting residues as sticks, bridging water molecules as red spheres a
and blue in the other subunit, oxygen atoms are red and nitrogen atoms are blue.the Drosophila Genomics Resource Center and cloned into a mod-
iﬁed pET-28a + plasmid, in which the FHA domain was fused to the
C-terminus of a His6-SMT3 tag. The protein was expressed in the
Escherichia coli BL21(DE3) strain (Novagen), which was induced
with 0.2 mM IPTG overnight at 25 C. The harvested cells were
resuspended in buffer P500 (50 mM sodium phosphate pH 7.6,
500 mM NaCl) and lysed using a JN-3000 PLUS cell disrupter
(JNBIO) and brief sonication. After clariﬁcation, the supernatant
was loaded onto a 5-ml HisTrap column (GE Healthcare). The pro-
tein was eluted with 250 mM imidazole in buffer P500. The His6-
SMT3 tag was cleaved with His-tagged ULP1 protease at 4 C for
0.5 h. After the imidazole concentration was lowered to 5 mM by
repeated steps of concentration and dilution, the protein sample
was passed over another HisTrap column to remove the cleaved
tag, uncleaved protein and His-tagged ULP1. The cleaved MU2
FHA domain was collected from the ﬂow-through and further puri-
ﬁed with Superdex-75 16/60 column in 5 mM HEPES-K pH 7.6 and
100 mM KCl. The peak fractions were collected and concentrated to
25 mg/ml. All puriﬁcation procedures were carried out at 4 C.
2.2. Crystallization and data collection
MU2 (1–101) was crystallized by mixing 1 ll of protein sample
(25 mg/ml, 5 mM HEPES-K pH 7.6 and 100 mM KCl) and 1 ll of
well solution (0.2 M calcium acetate pH 7.5 and 18% PEG 3350)L41
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Table 1
Data collection and reﬁnement statistics.
Crystal form Pt Native
Data collection
Space group P65 P65
Cell dimensions
a, b, c (Å) 100.2, 100.2, 38.2 99.9, 99.9, 38.3
a, b, c () 90, 90, 120 90, 90, 120
Wavelength (Å) 1.5418 0.9796
346 S. Luo, K. Ye / FEBS Letters 586 (2012) 344–349using the hanging drop vapor diffusion approach at 4 C. The ini-
tially obtained microcrystals were improved by microseeding and
macroseeding in drops containing 1 ll of protein solution
(10 mg/ml) and 1 ll of the well solution. Platinum derivatives were
prepared by soaking crystals in the well solution containing 1 mM
potassium tetrachloroplatinate for 5 h. Crystals were cryoprotected
in 20% glycerol in the well solution prior to freezing in liquid nitro-
gen. Diffraction data for native and derivative crystals were col-
lected at 100 K using a Rigaku machine at a wavelength of
1.5418 Å. A native dataset for the ﬁnal reﬁnement was collected
at the Shanghai Synchrotron Research Facility beamline BL17U.
Data were processed with Denzo/Scalepack or HKL2000 [28].
2.3. Structure determination and reﬁnement
The crystals belong to space group P65 with two molecules of
MU2 (1–101) in the asymmetric unit. The structurewas determined
by the single isomorphism replacement with anomalous scattering
(SIRAS) method using native and derivative datasets. Heavy atom
search, phase calculation and density modiﬁcation were conducted
with SHARP [29]. The model building and reﬁnement were com-
pleted using AutoBuild in Phenix [30], Coot [31] and Refmac [32].
The model was reﬁned to 1.9 Å and contained two MU2 FHA do-
mains with residues 1–99 and 3–99 as well as 135water molecules.
In the Ramachandran plot, 97.4% of the residues are in favored re-
gion and 2.6% in allowed region. The structure ﬁgures were created
using PyMOL [33]. The atomic coordinates and the structure factors
of the MU2 FHA structure have been deposited in the Protein Data
Bank under accession code 3UV0.
2.4. Gel ﬁltration
The gel ﬁltration experiments were conducted at 4 C with a
Superdex 75 10/300 column that was equilibrated in buffer P150
(50 mM sodium phosphate pH 7.6, 150 mM NaCl). The column
was calibrated with bovine serum albumin (67 kD), ovalbumin
(43 kD), chymotrypsinogen (25 kD), cytochrome C (12.4 kD) and
aprotinin (6.5 kD). MU2 (1–101), MDC1 (27–138) and the L127R
mutant of MDC1 (27–138) were loaded using 120 ll of each sam-
ple (350–500 lM).
2.5. Sedimentation equilibrium
The sedimentation equilibrium experiments were conducted
using an XL-I analytical ultracentrifuge (Beckman Coulter) that
was equipped with an An-60 Ti rotor and a six-channel center-
piece. The protein sample was exchanged to buffer P150 by gel ﬁl-
tration and loaded at a concentration of 67 lM. The protein was
centrifuged at 25 C at speeds of 25000, 30000 and 38000 rpm
and detected using UV absorbance at 280 nm. The data were glob-
ally ﬁtted as described previously [20].X-ray source Cu-K SSRF BL17U
Resolution range (Å) 25–2.80 (2.85–2.80) 20–1.90 (1.93–1.90)
Unique reﬂections 5591 17,428
Redundancy 16.9 (12.0) 11.1 (7.6)
I/r 16.7 (4.1) 24.8 (3.8)
Completeness (%) 100.0 (100.0) 98.6 (80.8)
Rmerge 0.206 (0.665) 0.122 (0.391)
Structure reﬁnement
Resolution range (Å) 18.9–1.90 (1.95–1.90)
No. reﬂections 16,472 (1180)
No. atoms 1636
Mean B factor (Å2) 18.2
Rwork 0.178 (0.164)
Rfree 0.227 (0.255)
RMSD bond length (Å) 0.015
RMSD bond angles () 1.591
Values for the data in the highest resolution bin are shown in parentheses.3. Results
3.1. Dimeric structure of MU2 FHA
We cloned, expressed, puriﬁed and crystallized a MU2 fragment
that contained residues 1–101. The structure was determined by
SIRAS phasing using platinum derivative and native crystals and
reﬁned to 1.9 Å resolution with an Rwork/Rfree of 0.178/0.227 and
excellent stereochemistry (Table 1). The structure adopts a typical
FHA fold with 11 b-strands (b1–b11) forming a two-sheet b-sand-
wich (Fig. 1B) [34]. The b-sheet 1 is composed of 6 strands in the
order b2–b1–b11–b10–b7–b8, whereas the b-sheet 2 is assembled
by 5 strands in the order b4–b3–b5–b6–b9. The individual subunitstructure of the MU2 FHA domain can be aligned to that of the
MDC1 FHA domain with a root mean square deviation (RMSD) of
0.923 Å over 46 Ca pairs (Fig. 1C) [20].
In crystal, the two subunits contact each other via b-sheet 2,
forming a symmetric homodimer. The strands b3, b5, b6 and b9
contact their counterparts in the other subunit in an antiparallel
alignment. The dyad axis is roughly perpendicular to the running
direction of these strands. The central area of the dimer interface
is mainly hydrophobic and comprises the residues Ile21, Arg23
(aliphatic part), Leu41, Ala42, Thr45, Cys47, Arg55 (aliphatic part),
Ala57, Leu59, Val60 and Val72 (Fig. 1D). In addition, on one side of
the dimer interface, Arg55 forms a salt bridge to Glu74 from the
same subunit and hydrogen bonds to the carbonyl oxygen atom
of Ala58 in the other subunit. On the other side of the dimer inter-
face, the planar guanidinium group of Arg23, which is stabilized by
a salt bridge with Glu31 from the same subunit, stacks over its
counterpart in the other subunit. Many water molecules were ob-
served to mediate the indirect inter-subunit contacts.
The dimer interface buries a solvent-accessible area of 872 Å2
for each subunit, accounting for 15.5% of total surface. Compared
to other crystallographic contacts, this chosen interface is the most
extensive: the next large interface covers an area of 488 Å2. To ver-
ify the dimer interface observed in the crystal, we introduced a few
single (T45R, L59R and I21R) and double mutations (T45R/L59R,
T45R/I21R) into the dimer interface. However, each of these mu-
tant proteins failed to be puriﬁed owing to severe aggregation
problems, suggesting that these residues at the dimer interface
are critical for the integrity of the structure.
Although the FHA domain of MDC1 and MU2 both form a dimer,
their dimer interfaces are different from each other: the MDC1 FHA
domain dimerizes via b-sheet 1, whereas the MU2 FHA domain
dimerizes via the opposite b-sheet 2 (Fig. 1C). Moreover, the dimer
interface is slightly asymmetric in the MDC1 FHA domain [20–22]
but is symmetric in the MU2 FHA domain.
3.2. MU2 FHA forms a stable dimer in solution
To test whether the MU2 FHA domain forms a dimer also in
solution, we analyzed its molecular size by gel ﬁltration chroma-
tography. The calculated apparent molecular weights were 27 kD
for the MU2 FHA domain, 24 kD for the MDC1 FHA domain con-
S. Luo, K. Ye / FEBS Letters 586 (2012) 344–349 347taining residues 27–138 and 15 kD for the L127R monomer mutant
of MDC1 (27–138) (Fig. 2A) [20]. These results demonstrate that
the MU2 FHA domain behaved as a dimer in solution.
By analytic ultracentrifugation sedimentation equilibrium
experiments, we showed that the MU2 FHA domain forms a highly
stable dimer with an apparent dissociation constant Kd of 0.19 nM
(Fig. 2B). By comparison, the MDC1 FHA dimer with unphosphory-
lated Thr4 is 50000-fold less stable with a Kd value of 9.2 lM
[20]. Notably, the MDC1 (27–138) dimer appeared smaller than
the MU2 (1–101) dimer in gel ﬁltration experiments. The MDC1
(27–138) dimer, which is weakly self-associated by itself, likely
partially dissociated into monomers, resulting in a delayed and
trailing peak in the elution proﬁle (Fig. 2A). In contrast, the stable
MU2 FHA dimer exhibited a symmetric elution peak, indicating a
homogenous dimer population. The dramatic difference in stability
between MU2 and MDC1 FHA dimers can be explained by the more
extensive dimer interface in MU2 (872 Å2) compared to that in
MDC1 (490 Å2) [20].25k
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Fig. 2. The MU2 FHA domain forms a stable dimer in solution. (A) Size exclusion
chromatography proﬁles of MU2 (1–101), MDC1 (27–138) and the L127R monomer
mutant of MDC1 (27–138). Each sample (350–500 lM) were loaded in 120 ll to a
Superdex 75 column. The elution positions of the calibration standards are
indicated on the top. (B) Analytic ultracentrifugation sedimentation equilibrium
analysis of the MU2 FHA domain. The lines show the best global ﬁt to three proﬁles
at spin speeds 25000, 30000 and 38000 rpm with a dimer dissociation constant Kd
of 0.19 nM.3.3. The MU2 FHA domain has a degenerate pThr-binding pocket
The pThr-binding pocket of FHA domain is situated at one end
of the b-sandwich and is composed of three loops between the
strands b3 and b4, b4 and b5 and b6 and b7 [13,34–44]. Although
the corresponding pocket in the MU2 FHA domain is not occluded
by dimerization, the pocket lacks three key residues for pThr
binding (Fig. 3A and B). The ﬁrst residue is an invariant serine res-
idue (Ser72 in MDC1), which forms a hydrogen bond to the phos-
phate group of bound pThr. This serine residue is replaced by
Glu40 in MU2 and the negatively charged side chain of Glu40
would repel the negatively charged phosphate group of pThr.
The second residue is located at the immediate C-terminal side
to the invariant serine and is frequently a positively charged ly-
sine or arginine residue (Lys73 in MDC1) that neutralizes the neg-
ative charge of pThr phosphate. This position is occupied by Leu41
in MU2. The third residue is an asparagine residue (Asn96 in
MDC1), which forms two hydrogen bonds with the backbone
atoms of the bound phosphopeptide. The b6–b7 loop in the
MU2 FHA domain is shorter by two residues compared to that
in the MDC1 FHA domain, which causes an alternative conforma-
tion of the loop and the absence of this key asparagine residue.
Nevertheless, an arginine residue (Arg26 in MU2 and Arg58 in
MDC1) in the b3–b4 loop that contacts the phosphate group and
the phosphopeptide backbone is preserved. These structural fea-
tures of the pThr-binding pocket strongly suggest that the MU2
FHA domain lacks the capability of binding pThr. However, we
cannot formally rule out the possibility that the MU2 FHA domain
binds phosphopeptide in an unconventional way. Experimentally,
we detected no binding of the MU2 FHA domain to a N-terminal
pThr4 peptide of MDC1 using isothermal titration calorimetry
(data not shown).4. Discussion
We have shown that the FHA domain of MU2 plays an evolu-
tionarily conserved role in dimerization. This ﬁnding extends the
structural correspondence between MU2 and MDC1 to their FHA
domains and supports that MU2 is the ortholog of MDC1. Never-
theless, MU2 and MDC1 FHA dimers show several marked struc-
tural differences. They dimerize via two opposite interfaces with
different intrinsic stability. The MDC1 FHA domain binds to pThr4
from the other molecule in dimer and this trans-interaction is re-
quired for formation of a stable dimer [20,21]. By contrast, the
MU2 FHA domain does not contain a functional pThr-binding pock-
et and an N-terminal tail that harbors a potential pThr site. The
MU2 FHA domain forms a highly stable dimer by itself, which
would obviate the need for additional intermolecular pThr-interac-
tion to stabilize dimer formation and prevent any dimerization-
dependent functional regulation. Hence, MU2 dimerization is con-
stitutive in Drosophila, whereas MDC1 dimerization is regulated in
mammals, which may contribute to the increased complexity in
mammalian DDR. Our results show that dimerization, rather than
pThr-binding, is conserved between the MU2 and MDC1 FHA
domains.
The MDC1 FHA domain was reported to bind CHK2 and ATM
through pThr-recognition [6,9]. These interactions should not be
conserved in Drosophila MU2 since it has a defective pThr-binding
pocket. A recombinant N-terminal fragment of MU2 (residues 1–
250) was shown to bind the MRN complex [24]. The MU2–MRN
interaction is also unlikely to occur through the conventional
FHA-mediated recognition of pThr sites in the MRN complex. Alter-
natively, the MU2–MRN interaction is likely mediated by the MU2
FHA domain in a pThr-independent manner or by the C-terminal
region of the FHA domain.
AB
Fig. 3. The MU2 FHA domain contains a degenerate pThr-binding pocket. Superposition of the structure of the MU2 FHA domain with the monomeric structure of the MDC1
FHA domain in complex with a pThr4 phosphopeptide (PDB code: 3UNN). The phosphopeptide and important phosphopeptide-binding residues are shown in stick-and-ball
representation and colored by atoms. (B) Structure based sequence alignment of the FHA domains of MU2, MDC1, CHK2 (PDB code: 1GXC) [42], NBS1 (3HUF) [36], Rad53
(ﬁrst, 1G6G) [34], Rad53 (second, 1J4L) [43], RNF8 (2PIE) [13], Dun1 (2JQL) [39], Ki67 (2AFF) [41], PNK (2W3O) [38], EmbR (2FF4) [40], Rv1827 (2KFU) [37], Odhi (2KB3) [44]
and TB39 (3POA) [35]. Phosphopeptide-binding residues are marked with solid cycles. The secondary structures and residue numbers are indicated for the MU2 FHA domain.
Omitted residues are indicated by ‘‘’’. Residues that are conserved in 95% and 80% of these sequences are shaded in black and gray, respectively.
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